Hirudin and excess bleeding. Implications for future use.
Zeymer
U
U
Medizinische Klinik II, Städtische Kliniken Kassel, Germany.
Neuhaus
K L
KL
D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D017326:Clinical Trials, Phase III as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D024764:Hirudin Therapy; D006629:Hirudins / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D013927:Thrombosis / Q000188:drug therapy
D006629:Hirudins